12/7
07:36 am
trda
Entrada Therapeutics, Inc. (NASDAQ: TRDA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Entrada Therapeutics, Inc. (NASDAQ: TRDA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
12/7
07:36 am
trda
Entrada Therapeutics, Inc. (NASDAQ: TRDA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Entrada Therapeutics, Inc. (NASDAQ: TRDA) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
11/6
09:07 am
trda
Rating for TRDA
Low
Report
Rating for TRDA
11/6
09:07 am
trda
Rating for TRDA
Low
Report
Rating for TRDA